Journal scan

Barriers in HIV-testing oncology patients may be physician-led

Swiss study reveals younger, non-migrant men with cancer more likely to be offered HIV testing

The success of modern pharmacological antiretroviral management means that many people are living now with HIV.

The changing epidemiology, ageing population and association of the disease with co-infection with oncogenic viruses, immunosuppression and other cancer-risk behaviours such as smoking, mean that non-AIDS-defining cancers are now the leading cause of non-AIDS death in people living with HIV.

Low uptake

Though the acceptance of HIV testing has previously been shown to be high in the oncology patient population, the actual uptake of HIV testing remains low.

Researchers from Lausanne, Switzerland, examined the inclination and disposition of patients and staff to HIV testing as part of the initial diagnostic work-up, and the rationale for not offering such testing.

Over a four-month period, of 239


Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first three months:

  • Customisable clinical dashboard featuring 200+ topics
  • Unlimited online access to all 10 RCNi Journals including Cancer Nursing Practice
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?